These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 6822746
1. Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species. Seidenfeld SM, Cooper BH, Smith JW, Luby JP, Mackowiak PA. J Infect Dis; 1983 Jan; 147(1):116-9. PubMed ID: 6822746 [Abstract] [Full Text] [Related]
2. Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts. Lombardi G, Gramegna G, Cavanna C, Poma G, Marangoni E, Michelone G. Mycopathologia; 1989 Apr; 106(1):31-4. PubMed ID: 2549421 [Abstract] [Full Text] [Related]
3. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole. Morace G, Manzara S, Dettori G. Chemotherapy; 1991 Apr; 37(1):23-31. PubMed ID: 2013239 [Abstract] [Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC. Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [Abstract] [Full Text] [Related]
15. The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan. Yang YL, Cheng MF, Wang CW, Wang AH, Cheng WT, Lo HJ, Hospitals T. Med Mycol; 2010 Mar; 48(2):328-34. PubMed ID: 20141372 [Abstract] [Full Text] [Related]
16. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. Anaissie E, Paetznick V, Proffitt R, Adler-Moore J, Bodey GP. Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):665-8. PubMed ID: 1748123 [Abstract] [Full Text] [Related]
18. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin. Ellepola AN. Med Princ Pract; 2012 Aug; 21(5):442-6. PubMed ID: 22678101 [Abstract] [Full Text] [Related]